SATB1 and hematologic disorder: Specifically, CD30 expression is limited to three hematologic diseases including cHL, anaplastic large cell lymphomas (ALCLs), and primary cutaneous CD30+ T-cell lymphoproliferative disorders in which SATB1 expression is associated with a better prognosis.